Standard antibiotic therapy
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), Catholic University of the Sacred Heart, Bassett Healthcare, Nazarbayev University Medical Center, Zensun Sci. & Tech. Co., Ltd.
Conditions
Acute BronchitisBacterial InfectionCatheter BacteremiaClostridium DifficileClostridium Difficile InfectionFebrile Urinary Tract InfectionRecurrent Urinary Tract InfectionStaphylococcus Aureus Infection
Phase 2
Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection
CompletedNCT02148601
Start: 2013-07-31End: 2014-11-30Updated: 2020-07-15
Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections
RecruitingNCT04859621
Start: 2021-05-08End: 2025-07-30Target: 150Updated: 2024-02-02
Phase 3
Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU
TerminatedNCT00307099
Start: 2006-10-31End: 2007-02-28Target: 460Updated: 2013-06-07
Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus
RecruitingNCT05117398
Start: 2023-06-23End: 2026-09-23Target: 406Updated: 2025-04-06
Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
RecruitingNCT05696093
Start: 2023-10-19End: 2026-12-31Target: 628Updated: 2025-05-20
Phase 4
Use of Bismuth Subsalicylate in Clostridium Difficile Colitis
WithdrawnNCT03592082
Start: 2018-03-01End: 2018-07-01Updated: 2018-07-19
Individualized Antibiotic Therapy in Children With Acute Uncomplicated Febrile Urinary Tract Infection
CompletedNCT05301023
Start: 2022-04-01End: 2024-06-08Updated: 2024-07-08